Taiwan-based diabetes management app Health2Sync has launched the latest version of its mobile app for approximately 200,000 users in Japan, which now integrates continuous glucose monitoring data from the Abbott FreeStyle LibreLink mobile app.
WHY IT IS IMPORTANT
This data integration, Health2Sync said in a statement, will enable comprehensive health management for people with diabetes. It enables them to view data on their diet, weight and blood pressure along with CGM data in their Health2Sync app. The app also shows exercise data collected by Fitbit.
This, in turn, will help them understand how to adjust their diet and lifestyle in time to improve blood sugar control and help them change their behavior towards treatment.
The latest version of the app is currently available in Japan and will be rolled out to other locations across Asia in the future.
THE LARGER CONTEXT
Health2Sync’s partner Abbott launched a mobile app in Japan earlier this year that enables discreet management with smartphone scanning. The Freestyle LibreLink app is available for reimbursement to Japanese patients currently on Intensive Insulin Therapy (IIT) or those using premixed insulin products more than twice a day after IIT.
Meanwhile last year in November, Health2Sync has partnered with Daikyo Astage, a Japanese housing management company, to provide a chronic disease management service to residents of the latter’s managed housing.
ON THE RECORD
“Our mission is to simplify the incredible amount of information and, in return, provide useful insights to patients,” said Ed Deng, Co-Founder and CEO of Health2Sync.
“In today’s environment where people with diabetes may not easily see their healthcare professionals and caregivers, the personalized self-management solutions that this collaboration enables are even more important,” said Caroline Johnson, general manager for diabetes care at Abbott commented.